Problematic Pharmaceutical Opioid Use Common in Noncancer Pain
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 15, 2024 -- For individuals with chronic noncancer pain (CNCP) treated with opioid analgesics, problematic pharmaceutical opioid use (POU) is common, according to a study published online Aug. 7 in Addiction.
Kyla H. Thomas, Ph.D., M.B.B.S., from the University of Bristol in the United Kingdom, and colleagues conducted a comprehensive systematic literature review and meta-analysis to examine the prevalence of POU in CNCP patients (aged 12 years and older) treated with opioid analgesics. POU was defined as dependence and opioid use disorder (D&OUD), signs and symptoms of D&OUD (S&S), aberrant behavior (AB), and at risk for D&OUD. Data were included from 148 studies with more than 4.3 million participants; 1 percent of studies had a high risk for bias.
The researchers found that the pooled prevalence was 9.3 percent (I2, 99.9 percent), 29.6 percent (I2, 99.3 percent), and 22 percent (I2, 99.8 percent) for D&OUD, S&S, and AB, respectively, while prevalence of those at risk for D&OUD was 12.4 percent (I2, 99.6 percent). Study setting, study design, and diagnostic tool affected prevalence. The findings should be interpreted with caution due to high heterogeneity, according to the researchers.
"Clinicians and policymakers need a more accurate estimate of the prevalence of problematic opioid use in pain patients so that they can gauge the true extent of the problem, change prescribing guidance if necessary, and develop and implement effective interventions to manage the problem," Thomas said in a statement. "Knowing the size of the problem is a necessary step to managing it."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Pain Diagnoses Seen for Most Patients With Cerebral Palsy
WEDNESDAY, Aug. 14, 2024 -- Most patients (89.0 percent) with cerebral palsy (CP) have one or more documented pain diagnoses, according to a research letter published online Aug...
Consistent Sex Disparity Seen in Pain Management
TUESDAY, Aug. 13, 2024 -- A consistent sex disparity is seen in pain management, with women less likely to be prescribed pain-related medications than men, according to a study...
Buprenorphine + Naloxone Safe for Opioid Addiction in Pregnancy
MONDAY, Aug. 12, 2024 -- Pregnancies exposed to buprenorphine combined with naloxone have similar or more favorable neonatal and maternal outcomes as those exposed to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.